[PDF] lww.com

[PDF][PDF] Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease

KJ Mayne, N Staplin, DF Keane… - Journal of the …, 2024 - journals.lww.com
BACKGROUND: Chronic kidney disease (CKD) is associated with fluid excess which can be
estimated by bioimpedance spectroscopy. We aimed to assess effects of sodium glucose co …
被引用次数：10 相关文章
[HTML] providence.org

[HTML][HTML] Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.

KJ Mayne, N Staplin, DF Keane… - Journal of the …, 2024 - digitalcommons.providence.org
Abstract SIGNIFICANCE STATEMENT: SGLT2 inhibitors reduce risk of kidney progression,
AKI, and cardiovascular disease, but the mechanisms of benefit are incompletely …

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

KJ Mayne, N Staplin, DF Keane, C Wanner, S Brenner… - 2024 - pubmed.ncbi.nlm.nih.gov
Significance statement SGLT2 inhibitors reduce risk of kidney progression, AKI, and
cardiovascular disease, but the mechanisms of benefit are incompletely understood …

Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease

K Mayne, R Haynes, D Keane, N Staplin… - Journal of the …, 2023 - ora.ox.ac.uk
BACKGROUND: Chronic kidney disease (CKD) is associated with fluid excess which can be
estimated by bioimpedance spectroscopy. We aimed to assess effects of sodium glucose co …
[HTML] nih.gov

[HTML][HTML] Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease

E The… - Journal of the American …, 2024 - ncbi.nlm.nih.gov
Background Chronic kidney disease (CKD) is associated with fluid excess which can be
estimated by bioimpedance spectroscopy. We aimed to assess effects of sodium glucose co …

Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease

KJ Mayne, N Staplin, DF Keane… - Journal of the …, 2023 - keele-repository.worktribe.com
BACKGROUND: Chronic kidney disease (CKD) is associated with fluid excess which can be
estimated by bioimpedance spectroscopy. We aimed to assess effects of sodium glucose co …

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.

KJ Mayne, N Staplin, DF Keane, C Wanner, S Brenner… - 2024 - mediatum.ub.tum.de
SIGNIFICANCE STATEMENT: SGLT2 inhibitors reduce risk of kidney progression, AKI, and
cardiovascular disease, but the mechanisms of benefit are incompletely understood …

Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease.

KJ Mayne, N Staplin, DF Keane, C Wanner… - Journal of the …, 2023 - europepmc.org
Background Chronic kidney disease (CKD) is associated with fluid excess which can be
estimated by bioimpedance spectroscopy. We aimed to assess effects of sodium glucose co …

Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease

KJ Mayne, N Staplin, DF Keane, C Wanner… - Journal of the …, 2023 - eprints.gla.ac.uk
Background: Chronic kidney disease (CKD) is associated with fluid excess which can be
estimated by bioimpedance spectroscopy. We aimed to assess effects of sodium glucose co …

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

KJ Mayne, N Staplin, DF Keane, C Wanner, S Brenner… - 2023 - journals.lww.com
Background CKD is associated with fluid excess that can be estimated by bioimpedance
spectroscopy. We aimed to assess effects of sodium glucose co-transporter 2 inhibition on …